You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • THU0178 Rates of Serious Infections and Malignancies among Rheumatoid Arthritis Patients Receiving Either Tnf-Blocker or Rituximab Therapy in Finland

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Poster Presentations. Rheumatoid arthritis - anti-TNF therapy
THU0178 Rates of Serious Infections and Malignancies among Rheumatoid Arthritis Patients Receiving Either Tnf-Blocker or Rituximab Therapy in Finland

 

Online download statistics by month:

Online download statistics by month: June 2014 to March 2024

AbstractFullPdf
Jun 2014301
Jul 20141100
Aug 2014801
Sep 2014700
Oct 2014401
Nov 2014500
Dec 2014402
Jan 20151501
Feb 2015603
Mar 20151004
Apr 20151003
May 2015200
Jun 2015100
Jul 2015401
Aug 20151904
Sep 2015801
Oct 2015100
Nov 2015201
Dec 2015301
Jan 2016501
Feb 20161301
Mar 2016300
Apr 2016100
May 2016201
Jun 2016401
Jul 2016500
Aug 2016600
Sep 2016601
Oct 2016500
Nov 2016600
Dec 2016600
Jan 2017400
Feb 2017300
Mar 2017900
Apr 2017300
May 2017400
Jun 2017400
Jul 2017400
Aug 20171200
Sep 2017400
Oct 20171000
Nov 2017200
Dec 20171000
Jan 20181200
Feb 2018201
Mar 2018801
Apr 2018800
May 20181201
Jun 2018801
Jul 2018600
Aug 2018800
Sep 20181200
Oct 2018600
Nov 2018200
Dec 2018800
Jan 2019200
Feb 2019400
Apr 2019200
May 2019200
Jun 2019100
Oct 2019600
Nov 2019200
Jan 2020700
Apr 2020902
Jun 2020600
Jul 2020400
Sep 2020801
Oct 2020400
Nov 2020200
Jan 2021500
May 2021200
Oct 2021200
Nov 2021600
Dec 2021800
Feb 2022200
Mar 2022400
Apr 2022800
May 2022600
Jun 2022200
Jul 20221200
Aug 2022600
Sep 2022200
Oct 2022400
Nov 2022800
Dec 2022800
Feb 2023600
Mar 2023200
May 2023800
Jul 2023200
Aug 2023200
Sep 2023400
Dec 20231200
Mar 20243600
Total562036